Ionis Pharmaceuticals vs Nasus Pharma
IONS and NSRX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IONS and NSRX compare
Nasus Pharma keeps more of each dollar of sales as profit, with a net margin of −0.47% compared with −56.9% at Ionis Pharmaceuticals.
Nasus Pharma scores higher on the StockData Score (6 against 3 for Ionis Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IONS | NSRX |
|---|---|---|
| Size and price | ||
| Market cap | $4.8B | – |
| Share price | $29.06 | $2.87 |
| Change, 1 year | −60.0% | −62.2% |
| Change, 5 years | −9.2% | – |
| Beta (5Y) | 0.68 | 1.33 |
| Employees | 1,402 | – |
| StockData Score | ||
| Total score | 3 | 6 (better) |
| Valuation score | 0 | 0 |
| Growth score | 2 (better) | 0 |
| Performance score | 0 | 1 (better) |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 5.0× | – |
| P/B | 12.3× | – |
| FCF yield | −12.8% | – |
| Fair value | $27.99 | – |
| Margin of safety | −3.8% | – |
| Growth | ||
| Revenue growth (TTM) | −0.71% | – |
| Revenue growth, 5Y average | 5.3% | – |
| Profitability | ||
| Gross margin | 98.2% | – |
| Operating margin | −58.8% | −0.40% (better) |
| Net margin | −56.9% | −0.47% (better) |
| FCF margin | −64.2% | −0.40% (better) |
| Return on equity | −108% (better) | −175% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −29.4× | – |
| Current ratio | 5.43 | 8.77 (better) |
| Altman Z-score | 0.22 | – |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 108% | 23.9% |
| Held by insiders | 0.80% | 59.3% |
| Insider net buying, 12 months | −$114M | $61.8K (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 12.8% | 1.9% |
Go deeper
- IONS stock overview
- IONS income statement
- IONS valuation and score
- NSRX stock overview
- NSRX income statement
- NSRX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.